Workflow
Proto Labs(PRLB)
icon
Search documents
Proto Labs(PRLB) - 2022 Q2 - Earnings Call Transcript
2022-08-06 11:49
Proto Labs, Inc. (NYSE:PRLB) Q2 2022 Results Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Jason Frankman - Vice President and Corporate Controller Robert Bodor - President and Chief Executive Officer Dan Schumacher - Chief Financial Officer Conference Call Participants Brian Drab - William Blair Jim Ricchiuti - Needham & Company Greg Palm - Craig-Hallum Capital Group Operator Greetings. And welcome to Proto Labs Second Quarter 2022 Earnings Conference Call. At this time, all parti ...
Proto Labs(PRLB) - 2022 Q2 - Quarterly Report
2022-08-05 16:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35435 Proto Labs, Inc. (Exact name of registrant as specified in its charter) Minnesota 41-1939628 (State or o ...
Proto Labs(PRLB) - 2022 Q1 - Earnings Call Transcript
2022-05-06 16:47
Proto Labs, Inc. (NYSE:PRLB) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Jason Frankman - Vice President, Corporate Controller Robert Bodor - President, Chief Executive Officer Daniel Schumacher - Interim Chief Financial Officer Conference Call Participants Brian Drab - William Blair Danny Eggerichs - Craig Hallum Jim Ricchiuti - Needham & Co. Ben Rose - Battle Road Research Operator Greetings and welcome to Proto Labs Q1 2022 Earnings Conference Call. At this time, all part ...
Proto Labs(PRLB) - 2022 Q1 - Quarterly Report
2022-05-06 16:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35435 Proto Labs, Inc. (Exact name of registrant as specified in its charter) Minnesota 41-1939628 (State or ...
Proto Labs(PRLB) - 2021 Q4 - Annual Report
2022-02-18 16:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35435 Proto Labs, Inc. (Exact name of Registrant as specified in its charter) Minnesota 41-193962 ...
Proto Labs(PRLB) - 2021 Q4 - Earnings Call Transcript
2022-02-11 16:55
Proto Labs Inc. (NYSE:PRLB) Q4 2021 Earnings Conference Call February 11, 2021 8:30 AM ET Company Participants Rob Bodor - President, Chief Executive Officer Dan Schumacher - Chief Financial Officer (interim) Jason Frankman - Vice President, Corporate Controller Conference Call Participants Brian Drab - William Blair Greg Palm - Craig Hallum Jim Ricchiuti - Needham & Co. Jared Maymon - Berenberg Capital Ben Rose - Battle Road Research Operator Greetings. Welcome to Proto Labs Fourth Quarter 2021 Earnings C ...
Proto Labs(PRLB) - 2022 Q4 - Earnings Call Presentation
2022-02-11 15:06
Earnings Presentation Q4 and FY 2021 ▸February 11, 2022 1 Safe Harbor ▸ These slides and accompanying oral presentation may contain forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied ...
Proto Labs(PRLB) - 2021 Q3 - Quarterly Report
2021-11-02 20:10
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35435 Proto Labs, Inc. (Exact name of registrant as specified in its charter) Minnesota 41-1939628 (State ...
Proto Labs(PRLB) - 2021 Q3 - Earnings Call Presentation
2021-11-01 14:42
1 Earnings Presentation Q3 2021 ▸October 28, 2021 Safe Harbor ▸ These slides and accompanying oral presentation may contain forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these ...
Proto Labs(PRLB) - 2021 Q3 - Earnings Call Transcript
2021-10-28 17:27
Proto Labs, Inc. (NYSE:PRLB) Q3 2021 Earnings Conference Call October 28, 2021 8:30 AM ET Company Participants Dan Schumacher - Investor Relations Rob Bodor - President and Chief Executive Officer John Way - Chief Financial Officer Conference Call Participants Brian Drab - William Blair Danny Eggerichs - Craig-Hallum Operator Greetings and welcome to the Protolabs Third Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to i ...